This is a routine insider sale tied to RSU vesting and tax withholding, not a discretionary open-market sale. No material signal for the stock. Monitor for any subsequent Form 4 filings to confirm execution, but no action warranted.
Price Chart
Executive Summary
Officer and Director Katherine Stueland filed a Form 144 notice of intent to sell 14,243 shares of GeneDx Holdings Corp. (WGS) with an estimated aggregate value of $1.21M. The shares are tied to anticipated vesting of restricted stock units on September 9 and September 16, 2026. This is a routine, pre-planned sale for tax-related purposes and represents a negligible fraction of the company's $2.5B market cap.
Key Facts
- Filing by Katherine Stueland, who serves as both Officer and Director of GeneDx Holdings Corp.
- Proposed sale of 14,243 shares of Class A Common Stock, estimated market value $1,208,100.
- Shares to be sold in connection with anticipated vesting of RSUs on September 9, 2026 (3,686 shares) and September 16, 2026 (10,557 shares).
- In the past 3 months, the reporting person sold 14,140 shares to cover tax withholding obligations upon RSU vesting.
- Sale planned on or after September 9, 2026 on NASDAQ.
Financial Impact
Proceeds of ~$1.21M, representing approximately 0.05% of WGS's $2.5B market cap.
Risk Factors
- Insider selling could be misinterpreted as a negative signal by the market, though the context of RSU vesting mitigates this.
- If the company's fundamentals deteriorate between the filing and the sale date, the sale could appear opportunistic.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-059938 |
| Document: 0001628280-26-059938-index.html | 0001628280-26-059938 |
| Document: 0001628280-26-059938.txt | 0001628280-26-059938 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | Insider Cluster | $85.27 $101.10 | ▲ +18.57% | ▲ +18.79% | $73.09 (−14.28%) |
Sep 1, 2026 4w ago | 144 | $86.72 $83.96 | ▼ −3.18% | ▼ −2.22% | $73.09 (−15.72%) |
Jul 27, 2026 9w ago | Press Release | $61.88 $67.86 | ▼ −9.66% | ▼ −7.39% | $73.09 (−18.12%) |
Jul 23, 2026 10w ago | Press Release | $63.38 $68.96 | ▼ −8.80% | ▼ −8.33% | $73.09 (−15.32%) |
Jun 16, 2026 15w ago | 8-K | $60.60 $58.08 | ▼ −4.16% | ▼ −1.93% | $73.09 (+20.61%) |
Jun 11, 2026 16w ago | Institutional Cluster | $59.92 $59.01 | ▼ −1.52% | ▼ −2.19% | $73.09 (+21.98%) |
Jun 8, 2026 16w ago | Insider Cluster | $56.33 $61.32 | ▲ +8.86% | ▲ +6.45% | $73.09 (+29.75%) |
May 20, 2026 19w ago | Insider Cluster | $47.33 $50.15 | ▲ +5.96% | ▲ +4.36% | $73.09 (+54.43%) |
Mar 26, 2026 27w ago | Insider Cluster | $61.35 $66.20 | ▼ −7.91% | ▼ −6.27% | $73.09 (−19.14%) |
Mar 4, 2026 30w ago | Insider Cluster | $79.47 $85.10 | ▼ −7.08% | ▼ −8.42% | $73.09 (+8.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access